APO Research
Talk to an analyst

APO RESEARCH · REPORT

Crizotinib Capsules

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Crizotinib Capsules Industry Growth and Trends Forecast to 2032

28 December 202594 pages

Choose your research edition.

Industry ResearchCrizotinib Capsules Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Crizotinib Capsules Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Crizotinib Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Crizotinib Capsules Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Crizotinib Capsules Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Crizotinib Capsules market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Crizotinib Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Crizotinib Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Crizotinib Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Crizotinib Capsules include Chia Tai Tianqing Pharmaceutical Group, Cipla Limited, Glenmark Pharmaceuticals, Natco Pharma, Pfizer, Jiangsu Hengrui Medicine and Qilu Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Crizotinib Capsules market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Crizotinib Capsules market size, estimates, and forecasts are presented in terms of sales volume (Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Crizotinib Capsules market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Crizotinib Capsules.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Crizotinib Capsules market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Crizotinib Capsules Market by Company

Chia Tai Tianqing Pharmaceutical Group

Cipla Limited

Glenmark Pharmaceuticals

Natco Pharma

Pfizer

Jiangsu Hengrui Medicine

Qilu Pharmaceutical

Crizotinib Capsules Segment by Type

200mg

250mg

Crizotinib Capsules Segment by Application

Hospital

Clinic

Others

Crizotinib Capsules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Crizotinib Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Crizotinib Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Crizotinib Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Crizotinib Capsules manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Crizotinib Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 200mg Table 2. Major Company of 250mg Table 3. Global Crizotinib Capsules Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Crizotinib Capsules Sales by Type (2021-2026) & (Tons) Table 5. Global Crizotinib Capsules Sales Market Share in Volume by Type (2021-2026) Table 6. Global Crizotinib Capsules Sales by Type (2021-2026) & (US$ Million) Table 7. Global Crizotinib Capsules Sales Market Share in Value by Type (2021-2026) Table 8. Global Crizotinib Capsules Price by Type (2021-2026) & (US$/Ton) Table 9. Global Crizotinib Capsules Sales by Type (2027-2032) & (Tons) Table 10. Global Crizotinib Capsules Sales Market Share in Volume by Type (2027-2032) Table 11. Global Crizotinib Capsules Sales by Type (2027-2032) & (US$ Million) Table 12. Global Crizotinib Capsules Sales Market Share in Value by Type (2027-2032) Table 13. Global Crizotinib Capsules Price by Type (2027-2032) & (US$/Ton) Table 14. North America Crizotinib Capsules Sales by Type (2021-2026) & (Tons) Table 15. North America Crizotinib Capsules Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Crizotinib Capsules Sales by Type (2021-2026) & (Tons) Table 17. Europe Crizotinib Capsules Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Crizotinib Capsules Sales by Type (2021-2026) & (Tons) Table 19. Asia-Pacific Crizotinib Capsules Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Crizotinib Capsules Sales by Type (2021-2026) & (Tons) Table 21. Latin America Crizotinib Capsules Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Crizotinib Capsules Sales by Type (2021-2026) & (Tons) Table 23. Middle East and Africa Crizotinib Capsules Sales by Type (2021-2026) & (US$ Million) Table 24. Crizotinib Capsules Industry Trends Table 25. Crizotinib Capsules Industry Drivers Table 26. Crizotinib Capsules Industry Opportunities and Challenges Table 27. Crizotinib Capsules Industry Restraints Table 28. Global Crizotinib Capsules Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Crizotinib Capsules Revenue Market Share by Company (2021-2026) Table 30. Global Crizotinib Capsules Sales by Company (2021-2026) & (Tons) Table 31. Global Crizotinib Capsules Sales Share by Company (2021-2026) Table 32. Global Crizotinib Capsules Market Price by Company (2021-2026) & (US$/Ton) Table 33. Global Crizotinib Capsules Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Crizotinib Capsules Major Company Production Sites and Headquarters Table 35. Global Crizotinib Capsules Company, Product Type & Application Table 36. Global Crizotinib Capsules Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Crizotinib Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Crizotinib Capsules Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Crizotinib Capsules Sales by Region (2021-2026) & (Tons) Table 41. Global Crizotinib Capsules Sales Market Share in Volume by Region (2021-2026) Table 42. Global Crizotinib Capsules Sales by Region (2021-2026) & (US$ Million) Table 43. Global Crizotinib Capsules Sales Market Share in Value by Region (2021-2026) Table 44. Global Crizotinib Capsules Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 45. Global Crizotinib Capsules Sales by Region (2027-2032) & (Tons) Table 46. Global Crizotinib Capsules Sales Market Share in Volume by Region (2027-2032) Table 47. Global Crizotinib Capsules Sales by Region (2027-2032) & (US$ Million) Table 48. Global Crizotinib Capsules Sales Market Share in Value by Region (2027-2032) Table 49. Global Crizotinib Capsules Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2027-2032) Table 50. Global Crizotinib Capsules Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Crizotinib Capsules Sales by Application (2021-2026) & (Tons) Table 52. Global Crizotinib Capsules Sales Market Share in Volume by Application (2021-2026) Table 53. Global Crizotinib Capsules Sales by Application (2021-2026) & (US$ Million) Table 54. Global Crizotinib Capsules Sales Market Share in Value by Application (2021-2026) Table 55. Global Crizotinib Capsules Price by Application (2021-2026) & (US$/Ton) Table 56. Global Crizotinib Capsules Sales by Application (2027-2032) & (Tons) Table 57. Global Crizotinib Capsules Sales Market Share in Volume by Application (2027-2032) Table 58. Global Crizotinib Capsules Sales by Application (2027-2032) & (US$ Million) Table 59. Global Crizotinib Capsules Sales Market Share in Value by Application (2027-2032) Table 60. Global Crizotinib Capsules Price by Application (2027-2032) & (US$/Ton) Table 61. North America Crizotinib Capsules Sales by Application (2021-2026) & (Tons) Table 62. North America Crizotinib Capsules Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Crizotinib Capsules Sales by Application (2021-2026) & (Tons) Table 64. Europe Crizotinib Capsules Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Crizotinib Capsules Sales by Application (2021-2026) & (Tons) Table 66. Asia-Pacific Crizotinib Capsules Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Crizotinib Capsules Sales by Application (2021-2026) & (Tons) Table 68. Latin America Crizotinib Capsules Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Crizotinib Capsules Sales by Application (2021-2026) & (Tons) Table 70. Middle East and Africa Crizotinib Capsules Sales by Application (2021-2026) & (US$ Million) Table 71. Chia Tai Tianqing Pharmaceutical Group Company Information Table 72. Chia Tai Tianqing Pharmaceutical Group Business Overview Table 73. Chia Tai Tianqing Pharmaceutical Group Crizotinib Capsules Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 74. Chia Tai Tianqing Pharmaceutical Group Crizotinib Capsules Product Portfolio Table 75. Chia Tai Tianqing Pharmaceutical Group Recent Development Table 76. Cipla Limited Company Information Table 77. Cipla Limited Business Overview Table 78. Cipla Limited Crizotinib Capsules Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 79. Cipla Limited Crizotinib Capsules Product Portfolio Table 80. Cipla Limited Recent Development Table 81. Glenmark Pharmaceuticals Company Information Table 82. Glenmark Pharmaceuticals Business Overview Table 83. Glenmark Pharmaceuticals Crizotinib Capsules Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 84. Glenmark Pharmaceuticals Crizotinib Capsules Product Portfolio Table 85. Glenmark Pharmaceuticals Recent Development Table 86. Natco Pharma Company Information Table 87. Natco Pharma Business Overview Table 88. Natco Pharma Crizotinib Capsules Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 89. Natco Pharma Crizotinib Capsules Product Portfolio Table 90. Natco Pharma Recent Development Table 91. Pfizer Company Information Table 92. Pfizer Business Overview Table 93. Pfizer Crizotinib Capsules Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 94. Pfizer Crizotinib Capsules Product Portfolio Table 95. Pfizer Recent Development Table 96. Jiangsu Hengrui Medicine Company Information Table 97. Jiangsu Hengrui Medicine Business Overview Table 98. Jiangsu Hengrui Medicine Crizotinib Capsules Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 99. Jiangsu Hengrui Medicine Crizotinib Capsules Product Portfolio Table 100. Jiangsu Hengrui Medicine Recent Development Table 101. Qilu Pharmaceutical Company Information Table 102. Qilu Pharmaceutical Business Overview Table 103. Qilu Pharmaceutical Crizotinib Capsules Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 104. Qilu Pharmaceutical Crizotinib Capsules Product Portfolio Table 105. Qilu Pharmaceutical Recent Development Table 106. North America Crizotinib Capsules Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 107. North America Crizotinib Capsules Sales by Country (2021-2026) & (Tons) Table 108. North America Crizotinib Capsules Sales Market Share by Country (2021-2026) Table 109. North America Crizotinib Capsules Sales Forecast by Country (2027-2032) & (Tons) Table 110. North America Crizotinib Capsules Sales Market Share Forecast by Country (2027-2032) Table 111. North America Crizotinib Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. North America Crizotinib Capsules Market Size by Country (2021-2026) & (US$ Million) Table 113. North America Crizotinib Capsules Market Share by Country (2021-2026) Table 114. North America Crizotinib Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. North America Crizotinib Capsules Market Share Forecast by Country (2027-2032) Table 116. Europe Crizotinib Capsules Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 117. Europe Crizotinib Capsules Sales by Country (2021-2026) & (Tons) Table 118. Europe Crizotinib Capsules Sales Market Share by Country (2021-2026) Table 119. Europe Crizotinib Capsules Sales Forecast by Country (2027-2032) & (Tons) Table 120. Europe Crizotinib Capsules Sales Market Share Forecast by Country (2027-2032) Table 121. Europe Crizotinib Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Europe Crizotinib Capsules Market Size by Country (2021-2026) & (US$ Million) Table 123. Europe Crizotinib Capsules Market Share by Country (2021-2026) Table 124. Europe Crizotinib Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Europe Crizotinib Capsules Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Crizotinib Capsules Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Crizotinib Capsules Sales by Country (2021-2026) & (Tons) Table 128. Asia-Pacific Crizotinib Capsules Sales Market Share by Country (2021-2026) Table 129. Asia-Pacific Crizotinib Capsules Sales Forecast by Country (2027-2032) & (Tons) Table 130. Asia-Pacific Crizotinib Capsules Sales Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Crizotinib Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Crizotinib Capsules Market Size by Country (2021-2026) & (US$ Million) Table 133. Asia-Pacific Crizotinib Capsules Market Share by Country (2021-2026) Table 134. Asia-Pacific Crizotinib Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Asia-Pacific Crizotinib Capsules Market Share Forecast by Country (2027-2032) Table 136. Latin America Crizotinib Capsules Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 137. Latin America Crizotinib Capsules Sales by Country (2021-2026) & (Tons) Table 138. Latin America Crizotinib Capsules Sales Market Share by Country (2021-2026) Table 139. Latin America Crizotinib Capsules Sales Forecast by Country (2027-2032) & (Tons) Table 140. Latin America Crizotinib Capsules Sales Market Share Forecast by Country (2027-2032) Table 141. Latin America Crizotinib Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Latin America Crizotinib Capsules Market Size by Country (2021-2026) & (US$ Million) Table 143. Latin America Crizotinib Capsules Market Share by Country (2021-2026) Table 144. Latin America Crizotinib Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Latin America Crizotinib Capsules Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Crizotinib Capsules Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Crizotinib Capsules Sales by Country (2021-2026) & (Tons) Table 148. Middle East and Africa Crizotinib Capsules Sales Market Share by Country (2021-2026) Table 149. Middle East and Africa Crizotinib Capsules Sales Forecast by Country (2027-2032) & (Tons) Table 150. Middle East and Africa Crizotinib Capsules Sales Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Crizotinib Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Crizotinib Capsules Market Size by Country (2021-2026) & (US$ Million) Table 153. Middle East and Africa Crizotinib Capsules Market Share by Country (2021-2026) Table 154. Middle East and Africa Crizotinib Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Middle East and Africa Crizotinib Capsules Market Share Forecast by Country (2027-2032) Table 156. Key Raw Materials Table 157. Raw Materials Key Suppliers Table 158. Crizotinib Capsules Distributors List Table 159. Crizotinib Capsules Customers List Table 160. Research Programs/Design for This Report Table 161. Authors List of This Report Table 162. Secondary Sources Table 163. Primary Sources List of Figures Figure 1. Crizotinib Capsules Image Figure 2. Global Crizotinib Capsules Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Crizotinib Capsules Market Size (2021-2032) & (US$ Million) Figure 4. Global Crizotinib Capsules Sales (2021-2032) & (Tons) Figure 5. 200mg Image Figure 6. Global 200mg Sales YoY Growth (2021-2032) & (Tons) Figure 7. 250mg Image Figure 8. Global 250mg Sales YoY Growth (2021-2032) & (Tons) Figure 9. Global Crizotinib Capsules Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Crizotinib Capsules Market Share by Type 2025 VS 2032 Figure 11. North America Crizotinib Capsules Sales Market Share in Volume by Type in 2025 Figure 12. North America Crizotinib Capsules Sales Market Share in Value by Type in 2025 Figure 13. Europe Crizotinib Capsules Sales Market Share in Volume by Type in 2025 Figure 14. Europe Crizotinib Capsules Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Crizotinib Capsules Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Crizotinib Capsules Sales Market Share in Value by Type in 2025 Figure 17. Latin America Crizotinib Capsules Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Crizotinib Capsules Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Crizotinib Capsules Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Crizotinib Capsules Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Crizotinib Capsules Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (Tons) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (Tons) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (Tons) Figure 29. Global Crizotinib Capsules Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Crizotinib Capsules Market Share by Application 2025 VS 2032 Figure 31. North America Crizotinib Capsules Sales Market Share in Volume by Application in 2025 Figure 32. North America Crizotinib Capsules Sales Market Share in Value by Application in 2025 Figure 33. Europe Crizotinib Capsules Sales Market Share in Volume by Application in 2025 Figure 34. Europe Crizotinib Capsules Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Crizotinib Capsules Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Crizotinib Capsules Sales Market Share in Value by Application in 2025 Figure 37. Latin America Crizotinib Capsules Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Crizotinib Capsules Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Crizotinib Capsules Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Crizotinib Capsules Sales Market Share in Value by Application in 2025 Figure 41. North America Crizotinib Capsules Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 42. North America Crizotinib Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Crizotinib Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Crizotinib Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Crizotinib Capsules Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 46. Europe Crizotinib Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Crizotinib Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Crizotinib Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Crizotinib Capsules Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 50. Asia-Pacific Crizotinib Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Crizotinib Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Crizotinib Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Crizotinib Capsules Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 54. Latin America Crizotinib Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Crizotinib Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Crizotinib Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Crizotinib Capsules Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 58. Middle East and Africa Crizotinib Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Crizotinib Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Crizotinib Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Crizotinib Capsules Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Crizotinib Capsules Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 200mg
  • 250mg
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Chia Tai Tianqing Pharmaceutical Group
  • Cipla Limited
  • Glenmark Pharmaceuticals
  • Natco Pharma
  • Pfizer
  • Jiangsu Hengrui Medicine
  • Qilu Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Crizotinib Capsules Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Crizotinib Capsules Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Crizotinib Capsules Market by Type
  6. 1.3.1 200mg
  7. 1.3.2 250mg
  8. 1.4 Global Crizotinib Capsules Market Size by Type
  9. 1.4.1 Global Crizotinib Capsules Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Crizotinib Capsules Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Crizotinib Capsules Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Crizotinib Capsules Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Crizotinib Capsules Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Crizotinib Capsules Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Crizotinib Capsules Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Crizotinib Capsules Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Crizotinib Capsules Industry Trends
  2. 2.2 Crizotinib Capsules Industry Drivers
  3. 2.3 Crizotinib Capsules Industry Opportunities and Challenges
  4. 2.4 Crizotinib Capsules Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Crizotinib Capsules Revenue (2021-2026)
  2. 3.2 Global Top Players by Crizotinib Capsules Sales (2021-2026)
  3. 3.3 Global Top Players by Crizotinib Capsules Price (2021-2026)
  4. 3.4 Global Crizotinib Capsules Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Crizotinib Capsules Major Company Production Sites & Headquarters
  6. 3.6 Global Crizotinib Capsules Company, Product Type & Application
  7. 3.7 Global Crizotinib Capsules Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Crizotinib Capsules Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Crizotinib Capsules Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Crizotinib Capsules Tier 1, Tier 2, and Tier 3
4 Crizotinib Capsules Regional Status and Outlook
  1. 4.1 Global Crizotinib Capsules Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Crizotinib Capsules Historic Market Size by Region
  3. 4.2.1 Global Crizotinib Capsules Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Crizotinib Capsules Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Crizotinib Capsules Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Crizotinib Capsules Forecasted Market Size by Region
  7. 4.3.1 Global Crizotinib Capsules Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Crizotinib Capsules Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Crizotinib Capsules Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Crizotinib Capsules by Application
  1. 5.1 Crizotinib Capsules Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Crizotinib Capsules Market Size by Application
  6. 5.2.1 Global Crizotinib Capsules Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Crizotinib Capsules Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Crizotinib Capsules Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Crizotinib Capsules Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Crizotinib Capsules Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Crizotinib Capsules Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Crizotinib Capsules Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Crizotinib Capsules Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Chia Tai Tianqing Pharmaceutical Group
  2. 6.1.1 Chia Tai Tianqing Pharmaceutical Group Company Information
  3. 6.1.2 Chia Tai Tianqing Pharmaceutical Group Business Overview
  4. 6.1.3 Chia Tai Tianqing Pharmaceutical Group Crizotinib Capsules Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Chia Tai Tianqing Pharmaceutical Group Crizotinib Capsules Product Portfolio
  6. 6.1.5 Chia Tai Tianqing Pharmaceutical Group Recent Developments
  7. 6.2 Cipla Limited
  8. 6.2.1 Cipla Limited Company Information
  9. 6.2.2 Cipla Limited Business Overview
  10. 6.2.3 Cipla Limited Crizotinib Capsules Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Cipla Limited Crizotinib Capsules Product Portfolio
  12. 6.2.5 Cipla Limited Recent Developments
  13. 6.3 Glenmark Pharmaceuticals
  14. 6.3.1 Glenmark Pharmaceuticals Company Information
  15. 6.3.2 Glenmark Pharmaceuticals Business Overview
  16. 6.3.3 Glenmark Pharmaceuticals Crizotinib Capsules Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Glenmark Pharmaceuticals Crizotinib Capsules Product Portfolio
  18. 6.3.5 Glenmark Pharmaceuticals Recent Developments
  19. 6.4 Natco Pharma
  20. 6.4.1 Natco Pharma Company Information
  21. 6.4.2 Natco Pharma Business Overview
  22. 6.4.3 Natco Pharma Crizotinib Capsules Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Natco Pharma Crizotinib Capsules Product Portfolio
  24. 6.4.5 Natco Pharma Recent Developments
  25. 6.5 Pfizer
  26. 6.5.1 Pfizer Company Information
  27. 6.5.2 Pfizer Business Overview
  28. 6.5.3 Pfizer Crizotinib Capsules Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Pfizer Crizotinib Capsules Product Portfolio
  30. 6.5.5 Pfizer Recent Developments
  31. 6.6 Jiangsu Hengrui Medicine
  32. 6.6.1 Jiangsu Hengrui Medicine Company Information
  33. 6.6.2 Jiangsu Hengrui Medicine Business Overview
  34. 6.6.3 Jiangsu Hengrui Medicine Crizotinib Capsules Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Jiangsu Hengrui Medicine Crizotinib Capsules Product Portfolio
  36. 6.6.5 Jiangsu Hengrui Medicine Recent Developments
  37. 6.7 Qilu Pharmaceutical
  38. 6.7.1 Qilu Pharmaceutical Company Information
  39. 6.7.2 Qilu Pharmaceutical Business Overview
  40. 6.7.3 Qilu Pharmaceutical Crizotinib Capsules Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Qilu Pharmaceutical Crizotinib Capsules Product Portfolio
  42. 6.7.5 Qilu Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Crizotinib Capsules Sales by Country
  2. 7.1.1 North America Crizotinib Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Crizotinib Capsules Sales by Country (2021-2026)
  4. 7.1.3 North America Crizotinib Capsules Sales Forecast by Country (2027-2032)
  5. 7.2 North America Crizotinib Capsules Market Size by Country
  6. 7.2.1 North America Crizotinib Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Crizotinib Capsules Market Size by Country (2021-2026)
  8. 7.2.3 North America Crizotinib Capsules Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Crizotinib Capsules Sales by Country
  2. 8.1.1 Europe Crizotinib Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Crizotinib Capsules Sales by Country (2021-2026)
  4. 8.1.3 Europe Crizotinib Capsules Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Crizotinib Capsules Market Size by Country
  6. 8.2.1 Europe Crizotinib Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Crizotinib Capsules Market Size by Country (2021-2026)
  8. 8.2.3 Europe Crizotinib Capsules Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Crizotinib Capsules Sales by Country
  2. 9.1.1 Asia-Pacific Crizotinib Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Crizotinib Capsules Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Crizotinib Capsules Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Crizotinib Capsules Market Size by Country
  6. 9.2.1 Asia-Pacific Crizotinib Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Crizotinib Capsules Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Crizotinib Capsules Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Crizotinib Capsules Sales by Country
  2. 10.1.1 South America Crizotinib Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Crizotinib Capsules Sales by Country (2021-2026)
  4. 10.1.3 South America Crizotinib Capsules Sales Forecast by Country (2027-2032)
  5. 10.2 South America Crizotinib Capsules Market Size by Country
  6. 10.2.1 South America Crizotinib Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Crizotinib Capsules Market Size by Country (2021-2026)
  8. 10.2.3 South America Crizotinib Capsules Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Crizotinib Capsules Sales by Country
  2. 11.1.1 Middle East and Africa Crizotinib Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Crizotinib Capsules Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Crizotinib Capsules Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Crizotinib Capsules Market Size by Country
  6. 11.2.1 Middle East and Africa Crizotinib Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Crizotinib Capsules Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Crizotinib Capsules Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Crizotinib Capsules Value Chain Analysis
  2. 12.1.1 Crizotinib Capsules Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Crizotinib Capsules Production Mode & Process
  7. 12.2 Crizotinib Capsules Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Crizotinib Capsules Distributors
  10. 12.2.3 Crizotinib Capsules Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst